Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Baxter
Colorcon
Federal Trade Commission
US Army
Farmers Insurance
Boehringer Ingelheim
Mallinckrodt
UBS
McKesson

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,964,212

« Back to Dashboard

Which drugs does patent 7,964,212 protect, and when does it expire?

Patent 7,964,212 protects BINOSTO and is included in one NDA.

This patent has ten patent family members in seven countries.
Summary for Patent: 7,964,212
Title:Effervescent compositions comprising phosphonates and methods related thereto
Abstract: The invention provides effervescent composition comprising a bisphosphonate, an acidic compound, an alkaline effervescing component, and optionally an anti-ulcer agent and methods of treating osteoporosis in a mammal using the effervescent compositions.
Inventor(s): Rosen; Christer (Jupiter, FL)
Assignee:
Application Number:12/367,928
Patent Claim Types:
see list of patent claims
Composition; Formulation;

Drugs Protected by US Patent 7,964,212

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Mission Pharma BINOSTO alendronate sodium TABLET, EFFERVESCENT;ORAL 202344-001 Mar 12, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,964,212

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,488,496 Effervescent compositions comprising bisphosphonates and methods related thereto ➤ Sign Up
8,449,906 Effervescent compositions comprising phosphonates and methods related thereto ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,964,212

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Spain 2448501 ➤ Sign Up
Spain 2380924 ➤ Sign Up
European Patent Office 2277503 ➤ Sign Up
European Patent Office 1490024 ➤ Sign Up
Denmark 1490024 ➤ Sign Up
Canada 2495886 ➤ Sign Up
Australia 2003284275 ➤ Sign Up
Australia 2003219999 ➤ Sign Up
Austria 541575 ➤ Sign Up
World Intellectual Property Organization (WIPO) 03075884 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Farmers Insurance
Citi
QuintilesIMS
Medtronic
Cipla
Deloitte
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot